DEVICE CATEGORY · KGG
Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
FDA classification: Unknown. Device class 3.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
TRUFILL n-BCA Liquid Embolic SystemP990040/S037 | Cerenovus, Inc. | PMA supplement | Oct 23, 2026 | FDA |
TRUFILL n-BCA Liquid Embolic SystemP990040/S038 | Cerenovus, Inc. | PMA supplement | May 26, 2026 | FDA |
TRUFILL n-BCA Liquid Embolic SystemP990040/S036 | Cerenovus, Inc. | PMA supplement | Aug 22, 2025 | FDA |
| Cerenovus, Inc. | PMA approval | Sep 25, 2000 | FDA |
Source information
Follow the FDA links to view the original records.


